Surface morphology of the orbitofrontal cortex in individuals at risk of psychosis: a multicenter study.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 13 06 2017
accepted: 16 03 2018
pubmed: 25 3 2018
medline: 4 12 2019
entrez: 25 3 2018
Statut: ppublish

Résumé

Changes in the surface morphology of the orbitofrontal cortex (OFC), such as a fewer orbital sulci and altered sulcogyral pattern of the 'H-shaped' orbital sulcus, have been reported in schizophrenia, possibly reflecting abnormal neurodevelopment during gestation. However, whether high-risk subjects for developing psychosis also exhibit these gross morphologic anomalies is not well documented. This multicenter MRI study from four scanning sites in Japan investigated the distribution of the number of intermediate and posterior orbital sulci, as well as the OFC sulcogyral pattern, in 125 individuals with an at-risk mental state (ARMS) [of whom 22 later developed psychosis (ARMS-P) and 89 did not (ARMS-NP)] and 110 healthy controls. The ARMS group as a whole had a significantly lower number of intermediate and posterior orbital sulci compared with the controls, which was associated with prodromal symptomatology. However, there was no group difference in OFC pattern distribution. The ARMS-P and -NP groups did not differ in OFC surface morphology. These results suggest that gross morphology of the OFC in high-risk subjects may at least partly reflect neurodevelopmental pathology related to vulnerability to psychosis.

Identifiants

pubmed: 29572660
doi: 10.1007/s00406-018-0890-6
pii: 10.1007/s00406-018-0890-6
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-406

Subventions

Organisme : JSPS KAKENHI
ID : JP26461739
Organisme : JSPS KAKENHI
ID : JP24390281
Organisme : JSPS KAKENHI
ID : JP26461738
Organisme : JSPS KAKENHI
ID : JP16H06395
Organisme : JSPS KAKENHI
ID : 16H06399
Organisme : JSPS KAKENHI
ID : 16K21720
Organisme : JSPS KAKENHI
ID : 16H06280
Organisme : The Health and Labour Sciences Research Grants for Comprehensive Research on Persons with Disabilities from the Japan Agency for Medical Research and Development
ID : 16dk0307029h0003
Organisme : The SENSHIN Medical Research Foundation
ID : Psychiatry 16 (general): 2-30
Organisme : Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from AMED
ID : 17dm0207004h0004

Références

J Comp Neurol. 2000 Jun 19;422(1):35-54
pubmed: 10842217
Schizophr Res. 2003 Mar 1;60(1):21-32
pubmed: 12505135
Nat Neurosci. 2003 Mar;6(3):309-15
pubmed: 12548289
Lancet. 2003 Jan 25;361(9354):281-8
pubmed: 12559861
Br J Psychiatry. 2003 Jun;182:518-24
pubmed: 12777343
Schizophr Res. 2004 Apr 1;67(2-3):131-42
pubmed: 14984872
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Am J Psychiatry. 2004 Mar;161(3):398-413
pubmed: 14992962
Prog Neurobiol. 2004 Apr;72(5):341-72
pubmed: 15157726
Schizophr Bull. 2005 Jul;31(3):672-96
pubmed: 16020551
Brain. 2007 Mar;130(Pt 3):693-707
pubmed: 17347256
J Clin Psychopharmacol. 2009 Oct;29(5):421-5
pubmed: 19745640
Psychol Med. 2010 Sep;40(9):1409-22
pubmed: 20085668
Eur Psychiatry. 2010 Oct;25(6):366-72
pubmed: 20542665
Psychiatry Clin Neurosci. 2010 Jun;64(3):318-26
pubmed: 20602731
Schizophr Res. 2010 Aug;121(1-3):55-65
pubmed: 20605415
Early Interv Psychiatry. 2009 Feb;3(1):5-9
pubmed: 21352169
Arch Gen Psychiatry. 2012 Mar;69(3):220-9
pubmed: 22393215
Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):15-24
pubmed: 22821623
Soc Cogn Affect Neurosci. 2014 Feb;9(2):232-9
pubmed: 23160816
Schizophr Res. 2013 Jan;143(1):116-24
pubmed: 23219075
Soc Cogn Affect Neurosci. 2014 Apr;9(4):520-8
pubmed: 23386741
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:168-77
pubmed: 23485592
JAMA Psychiatry. 2013 Aug;70(8):793-802
pubmed: 23739772
Schizophr Res. 2014 Mar;153(1-3):18-24
pubmed: 24530137
Schizophr Res. 2014 Apr;154(1-3):93-9
pubmed: 24630136
PLoS One. 2014 Jun 18;9(6):e99667
pubmed: 24941136
Biol Psychiatry. 2015 Jan 15;77(2):147-57
pubmed: 25034946
Hum Brain Mapp. 2015 Mar;36(3):1138-50
pubmed: 25409629
Psychiatry Clin Neurosci. 2015 Aug;69(8):440-7
pubmed: 25601291
Front Hum Neurosci. 2015 Jan 13;8:1047
pubmed: 25628553
J Neurosci. 2015 Jan 28;35(4):1648-58
pubmed: 25632140
Eur Arch Psychiatry Clin Neurosci. 2016 Feb;266(1):15-23
pubmed: 25757375
Psychiatry Res. 2015 Nov 30;234(2):280-3
pubmed: 26409572
Psychiatry Res Neuroimaging. 2016 Apr 30;250:29-32
pubmed: 27017422
Psychol Med. 2016 Oct;46(13):2771-83
pubmed: 27396386
Science. 1988 Jul 8;241(4862):170-6
pubmed: 3291116
Ann Neurol. 1977 Jan;1(1):86-93
pubmed: 560818
Nature. 1997 Jan 23;385(6614):313-8
pubmed: 9002514

Auteurs

Mihoko Nakamura (M)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan. mihokon@med.u-toyama.ac.jp.

Tsutomu Takahashi (T)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan.

Yoichiro Takayanagi (Y)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan.

Daiki Sasabayashi (D)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan.

Naoyuki Katagiri (N)

Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.

Atsushi Sakuma (A)

Department of Psychiatry, Tohoku University Hospital, Sendai, Japan.

Chika Obara (C)

Department of Psychiatry, Tohoku University Hospital, Sendai, Japan.

Shinsuke Koike (S)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Hidenori Yamasue (H)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Atsushi Furuichi (A)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan.

Mikio Kido (M)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan.

Yumiko Nishikawa (Y)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan.

Kyo Noguchi (K)

Department of Radiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.

Kazunori Matsumoto (K)

Department of Psychiatry, Tohoku University Hospital, Sendai, Japan.
Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Japan.

Masafumi Mizuno (M)

Department of Neuropsychiatry, Toho University School of Medicine, Tokyo, Japan.

Kiyoto Kasai (K)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
International Research Center for Neurointelligence (WPI-IRCN), UTIAS, The University of Tokyo, Tokyo, Japan.

Michio Suzuki (M)

Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH